Clinical Trials Sponsored by Claudio Sandroni

Total 344 results

Claudio Gobbi
Ospedale Civico, Lugano

Completed

Natalizumab De-escalation With Interferon Beta-1b

Relapsing-remitting Multiple Sclerosis

Switzerland
Claudio Castanos

Completed

Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans

Bronchiolitis Obliterans
Claudio Nigg
University of Bern

Completed

A Study to Promote Physical Activity Motivation in Cardiovascular Disease Patients (iPAL)

Cardiovascular Diseases

Switzerland
Fondazione Policlinico Universitario Agostino Gemelli...
Antonio Maria Dell Anna; Sofia Cacciola; Claudio Sandroni; Mauro Pittiruti; Cesare... and other collaborators

Completed

Suitability of PICC for Transpulmonary Thermodilution Compared to CICC

Hemodynamic Monitoring | Peripherally Inserted Central Catheters | Transpulmonary Thermodilution | CVC

Italy
Claudio Gobbi
Bayer

Terminated

Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis

Switzerland
Fondazione Policlinico Universitario Agostino Gemelli...
Antonio Maria Dell Anna; Sofia Cacciola; Claudio Sandroni; Giulia Chiuri; Mauro Pittiruti and other collaborators

Completed

Single-lumen 5Fr and Triple-lumen 6Fr PICCs Are Accurate for Hemodynamic Measurement by Transpulmonary Thermodilution.

Hemodynamic Monitoring | Peripherally Inserted Central Catheters | Centrally Inserted Central Catheter | Transpulmonary Thermodilution

Italy
Fondazione Sandro Pitigliani

Completed

To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy (TREnd)

Breast Cancer

Italy
Claudia Aristizábal
Sanitas University

Completed

Non-immersive Virtual Reality for Pediatric Pain Management

Procedural Pain

Colombia
Fondazione Sandro Pitigliani

Completed

EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer (EFFECT)

Breast Cancer

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Recruiting

Italian Network MDS Registry (FISM_registry)

Myelodysplastic-Myeloproliferative Diseases

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Terminated

Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS

Myelodysplastic Syndromes

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Recruiting

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care (FISiM-NGS-MDS)

MDS (Myelodysplastic Syndrome)

Italy
Claudio Mendes Pannuti

Completed

Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy (EsCAPE2)

Periodontitis
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Completed

Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy (BIOFER12)

Myelofibrosis | Aplastic Anemia | Myelodysplasia

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Withdrawn

Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes (CLO2009AISSM05)

Myelodysplastic Syndromes

Italy
Institut Claudius Regaud

Recruiting

Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae (LAMBEAU STEPA)

Head and Neck Cancer | Oropharynx Cancer | Oral Cavity Cancer

France
Institut Claudius Regaud

Recruiting

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy (BLAD-RAD01)

Urothelial Bladder Cancer

France
Institut Claudius Regaud

Recruiting

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy (MINER)

Solid Cancers

France
Institut Claudius Regaud

Recruiting

Prospective Melanoma Database

Melanoma

France
Institut Claudius Regaud

Active, not recruiting

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm (COCABIO000)

Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm

France
Institut Claudius Regaud

Completed

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO) (CREDO)

METASTATIC CANCER

France
Institut Claudius Regaud

Completed

Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer. (CARMMYC)

Breast Cancer

France
Institut Claudius Regaud

Completed

Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up Compared to Standard Follow-up. (ADHESIPH)

Metastatic Solid Tumor

France
Institut Claudius Regaud

Completed

A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection. (MEDIRAD)

Differentiated Thyroid Cancer

France
Institut Claudius Regaud

Withdrawn

Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA) (PROSTIRNA)

Prostatic Cancer, Castration-Resistant

France
Institut Claudius Regaud

Unknown

Evaluation of the Adhesion to the GENEPY Network (GENEPY)

Hereditary Breast and Ovarian Cancer | Hereditary Cancer Syndrome | Hereditary Colorectal Endometrial Cancer Syndrome

France
Institut Claudius Regaud

Terminated

Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment Sequella (GRATSEC)

Breast Cancer

France
Institut Claudius Regaud

Terminated

Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma

Soft Tissue Sarcoma of Members

France
Institut Claudius Regaud

Completed

Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment (EVAL'COACH)

Solid Tumors

France
Institut Claudius Regaud

Completed

Pharmacology of Adjuvant Hormonotherapy in Breast Cancer (PHACS)

Hormono-depending Adjuvant Breast Cancer

France
Institut Claudius Regaud

Completed

Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

Genital Neoplasms, Male

France
Institut Claudius Regaud

Completed

Determination of Carboplatin's Optimal Plasmatic Exposure

Neoplasms

France
Institut Claudius Regaud

Completed

Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.

Breast Neoplasms

France
Claudia Guerrieri

Enrolling by invitation

Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer (SURE-02)

Muscle-invasive Urothelial Carcinoma of the Bladder

Italy
Fondazione Sandro Pitigliani
Novartis

Active, not recruiting

FACILE: FeAsibility of First-line riboCIclib in oLdEr Patients With Advanced Breast Cancer (FACILE)

Breast Cancer

Italy
Ospedale Sandro Pertini, Roma

Completed

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.

Aloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC)
Ospedale Sandro Pertini, Roma

Recruiting

Radial accEss Crossover for PErcutaneous Coronary Procedures And ouTcome: the REPEAT Study (REPEAT)

Percutaneous Coronary Intervention | Coronary Angiography

Italy
Ospedale Sandro Pertini, Roma

Completed

EXTended pRotective Curtain Under Table to Reduce Operator RAdiation Dose in Percutaneous Coronary Procedures (EXTRA-RAD)

Coronary Disease | Radiation | X-rays; Effects

Italy
Matteo Santoni

Recruiting

ARON-2 Study-Multicentric International Retrospective Study

Urothelial Carcinoma

Italy
Claudia Spies

Completed

Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care

Sedation in Intensive Care Unit Patients

Germany
Claudia Spies

Completed

Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study

Septic Shock

Germany
Claudia Spies

Completed

Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex)

Delirium | Postoperative Cognitive Deficit (POCD)

Germany
Claudia Spies

Completed

Optimization of the Anesthetic Regimen Using the SmartPilot® System and Influence on Different Outcome Parameters - a Pilot Study.

Postoperative Cognitive Disturbances

Germany
Claudia Lorenz-Schlüter

Terminated

Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin (MyoPac)

Metastatic Breast Cancer

Germany
Claudia Spies

Terminated

Effectiveness of Etoricoxib as an Additive Analgesic to Epidural Analgesia in Colon or Rectal Fast-track Surgery

Post-operative Pain

Germany
Ospedale Sandro Pertini, Roma

Completed

RAdiation Dose In percutANeuos Coronary Procedures Through Transradial Approach (RADIANT Observational Study) (RADIANT)

Radiation Exposure

Italy
Ospedale Sandro Pertini, Roma

Completed

RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study (RODEO)

Radiation Injuries
Ospedale Sandro Pertini, Roma

Completed

RAdiation Dose In percutAneuos Coronary Procedures Through TransradIal apprOach Using Dedicated radiatioN Shields (RADIATION)

Myocardial Ischemia

Italy
Ospedale Sandro Pertini, Roma

Completed

Hand Grip Test and Transradial Coronary Procedures (HANGAR)

Radial Artery Occlusion

Italy
Claudio Gobbi
Merck AG Switzerland

Active, not recruiting

Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy

Multiple Sclerosis

Switzerland

3

Subscribe